0001062993-23-001046.txt : 20230118 0001062993-23-001046.hdr.sgml : 20230118 20230118184239 ACCESSION NUMBER: 0001062993-23-001046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230114 FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brenner Erin K. CENTRAL INDEX KEY: 0001881042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39969 FILM NUMBER: 23535508 MAIL ADDRESS: STREET 1: C/O PEAR THERAPEUTICS, INC. STREET 2: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001835567 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 854103092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Thimble Point Acquisition Corp. DATE OF NAME CHANGE: 20201208 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-01-14 0001835567 Pear Therapeutics, Inc. PEAR 0001881042 Brenner Erin K. C/O PEAR THERAPEUTICS, INC. 200 STATE STREET, 13TH FLOOR BOSTON MA 02109 0 1 0 0 Chief Product Dev. Officer Common Stock 2023-01-14 4 M 0 22000 0.00 A 52000 D Restricted Stock Units 2023-01-14 4 M 0 22000 0 D Common Stock 22000 44667 D Each restricted stock unit represents a contingent right to receive one share of PEAR common stock. The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025. /s/ Stacie S. Aarestad, Attorney-in-Fact 2023-01-18